“Are we losing the battle against heart disease?” asks the lead article featured in the January 2023 issue of the AARP Bulletin. “Despite breathtaking medical...
CommonSpirit Health, one of the nation’s largest health systems is facing a proposed class-action lawsuit over a ransomware attack it suffered last fall. How perilous is this for a health...
An experimental Alzheimer’s drug that moderately slows cognitive decline was approved by the Food and Drug Administration (FDA) on Friday. The drug, called lecanemab, was granted conditional approval based on...
